Abiopharma

Replace - Annual General Meeting :: Voluntary

Zepzelca® (lurbinectedin) and Atezolizumab(Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer

Guardant Health, Inc. - Guardant Health Wins FastCompany’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening

Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals Announces a Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules

Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention

Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension

Axsome Therapeutics Announces Availability ofSYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults

Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

MacroGenics and Sagard Healthcare Partners Enter intoZYNYZ® Royalty Purchase Agreement

Anixa Biosciences Breast Cancer Vaccine Receives National News Coverage